Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02724371 · ClinicalTrials.gov registry record · NA
A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction
A NA study of Breast Reconstruction, Revision Breast Reconstruction, sponsored by Mentor Worldwide.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 20
- Study locations
NCT02724371: Active NA study of Breast Reconstruction, Revision Breast Reconstruction, sponsored by Mentor Worldwide.
NCT02724371 is a NA study of Breast Reconstruction, Revision Breast Reconstruction that is active but no longer recruiting, run by Mentor Worldwide. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02724371, a NA study of Breast Reconstruction, Revision Breast Reconstruction, is active but no longer recruiting, sponsored by Mentor Worldwide.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study will evaluate the safety and effectiveness with the Mentor MemoryGel® Larger Size Ultra High Profile (UHP-L) Breast Implants.
Conditions Studied
Interventions
- DEVICE Mentor Larger Size MemoryGel Ultra High Profile Breast Implant
Study Locations (20)
California
- Adventist Health Bakersfield - Bakersfield
- Susan E Downey MD, Inc - Burbank
- Liu Plastic Surgery - Los Gatos
- Stanford University School of Medicine - Stanford
Ohio
- Plastic Surgery Institute of Dayton - Centerville
- The Plastic Surgery Group - Cincinnati
- The Cleveland Clinic - Cleveland
- The Ohio State University Plastic Surgery - Columbus
Arizona
- Mosharrafa Plastic Surgery - Phoenix
- Mayo Clinic Arizona - Scottsdale/Phoenix (MCSB) - Phoenix
- Andres Plastic Surgery - Scottsdale
Georgia
- Buckhead Plastic Surgery, P.C - Atlanta
- Georgia Institute of Plastic Surgery - Savannah
Alabama
- Plastic Surgery Associates of Montgomery - Montgomery
Indiana
- The Centre, PC - Mishawaka
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Kansas
- The University of Kansas - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
What the registry record for NCT02724371 still lists
NCT02724371 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Breast Reconstruction, Revision Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Mentor Larger Size MemoryGel Ultra High Profile Breast Implant is the first listed.
NCT02724371 names 20 study sites across 11 states, led by California, Ohio, Arizona.
Frequently Asked Questions
What is clinical trial NCT02724371 about?
NCT02724371 is a clinical study titled "A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction". The study will evaluate the safety and effectiveness with the Mentor MemoryGel® Larger Size Ultra High Profile (UHP-L) Breast Implants.
What is the current status of trial NCT02724371?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2016-04-01. Estimated completion is 2029-01-31.
What conditions does trial NCT02724371 study?
This clinical trial studies the following conditions: Breast Reconstruction, Revision Breast Reconstruction.
What interventions are being tested in trial NCT02724371?
The interventions under investigation include: Mentor Larger Size MemoryGel Ultra High Profile Breast Implant (DEVICE).
Who is sponsoring clinical trial NCT02724371?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02724371 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02724371's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI